학술논문

A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer
Document Type
Article
Source
In: British Journal of Cancer. (British Journal of Cancer, 5 October 2023, 129(6):965-973)
Subject
Language
English
ISSN
15321827
00070920